Avanos Medical, Inc. has entered a definitive agreement to be acquired by American Industrial Partners in an all-cash deal valued at $1.272 billion. The acquisition, offering significant premiums to current stock prices, is expected to close in the second half of 2026, marking a transition to a private company.
- Avanos Medical reported earnings of $0.22 per share, beating estimates and showing growth. - Company's revenues of $166.1 million exceeded expectations and have shown consistency in surpassing estimates. - Stock performance has declined but the future outlook may depend on earnings and industry trends. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings